- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/06 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 233/06
Total number of patents in this class: 77
10-year publication summary
|
5
|
6
|
3
|
6
|
8
|
7
|
2
|
2
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 360 |
5 |
| Celltrion, Inc. | 412 |
4 |
| Curasen Therapeutics, Inc. | 52 |
3 |
| Mainstream Pine Products, LLC | 60 |
3 |
| F. Hoffmann-La Roche AG | 7808 |
2 |
| E. I. du Pont de Nemours and Company | 3486 |
2 |
| California Institute of Technology | 4036 |
2 |
| Dow Global Technologies LLC | 10994 |
2 |
| Agency for Science, Technology and Research | 3749 |
2 |
| University of Southern California | 2139 |
2 |
| The Governing Council of University of Toronto | 7 |
2 |
| Nanyang Technological University | 2223 |
2 |
| Tokyo University of Science Foundation | 442 |
2 |
| Ocuphire Pharma, Inc. | 21 |
2 |
| Bristol-myers Squibb Company | 4757 |
1 |
| Centre National de La Recherche Scientifique | 11059 |
1 |
| FUJIFILM Corporation | 30594 |
1 |
| Massachusetts Institute of Technology | 10282 |
1 |
| The Johns Hopkins University | 5913 |
1 |
| Commissariat à l'énergie atomique et aux energies alternatives | 11127 |
1 |
| Other owners | 36 |